Mission3 and RealityCorp Announce Strategic Alliance
Phoenix, AZ-March 4, 2009-Mission3, Inc., a leading provider of program delivery for the Life Sciences industry, announced today that it has entered into a strategic partnership with Re@lityCorp in order to provide cutting edge technology to emerging Life Science companies. With Re@lityCorp’s unparalleled QA and Testing expertise, along with their trusted practices and standards, and Mission3’s robust suite of
project planning, document management, regulatory submission, and collaborative authoring, the alliance promises to provide efficient, accurate execution of services for client companies in today’s challenging operational environment.
“We are pleased to partner with a company like Re@lityCorp. Given their expertise in the validation and testing arena and their knowledge of technology delivery via SaaS, this partnership can really highlight the value chain for life science companies. With the incredible tightness in the economy and capital markets right now, both Mission3 and Re@lityCorp offer companies mission critical technology without making huge
investments in working capital as well as time and resources.”, said Dirk Karsten Beth, President and Founder of Mission3.
“Our clients are always under significant time and resource constraints to deliver projects on schedule and within budget. They are looking for timely and easily accessible ways to access, maintain, approve, retrieve, and collaborate on project related documentation. Mission3’s web based, project integrated electronic documentation management solution is a home run for our clients and users. We are really looking forward to extend the Mission3 platform and value to our client base”, said Carlton Schowe, President of Re@lityCorp.
About Mission3, Inc.
Mission3 is a leading provider of on-demand program delivery software that merges cutting edge technology with affordability, exclusively for the unique needs of the Life Sciences industry. Mission3 OnDemand is a fully integrated, 21 CFR Part 11 compliant, Document, Project, and Regulatory Submission Management suite that is truly web-based and offered in an collaborative, on-demand (SaaS) environment. Designed for rapid deployment and ease of use, Mission3 OnDemand 3.0 manages all documents within business areas governed by world wide regulatory bodies and corresponding submissions. For more information go to: www.mission3.com
About Re@lity Corp
Re@lityCorp provides state-of-art and industry leading outsourced QA data validation solutions. Our Software as a Service (SaaS) offers our clients unparallel new configuration and amendment deployment speed and leading edge functionality that typically saves our clients up to a 50% reduction in project time and cost without compromising quality. Re@lityCorp’s QA testing platform offers a very compelling value
proposition to our customers. For more information go to: www.realitycorp.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
